JULIAN MCLEOD: Open Payments
NPI 1003898107 · ROCKY MOUNT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 53 payments from 12 companies in 2025. Trend: 2023 $1,901 · 2024 $1,868 · 2025 $1,138
Food & beverage: $1,138
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $260 |
| Lilly USA, LLC | 13 | $208 |
| Otsuka America Pharmaceutical, Inc. | 3 | $180 |
| ABBVIE INC. | 6 | $146 |
| Corcept Therapeutics | 4 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Eisai Inc. | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
Products named: OTEZLA, JARDIANCE, MOUNJARO, Korlym, CREON, ZEPBOUND, REXULTI, VRAYLAR.
Industry payments across NC — which companies pay providers there.
